February 2010

Editor's Note

• Editorial Catalysts

Feature Article

• The Industry Outlook For 2010
• The Potential Of Personalized Medicine

Pharma Development & Manufacturing

• Generics, Biologics, And Other Industrywide Trends

Research And Development & Clinical Trials

• The Promise Of Peptides And Proteins

Information Technology

• Is the Future Of High- Performance Computing For Life Sciences Cloudy?

Regulatory Compliance/FDA

• In The FDA Spotlight: Investigators And Sponsors
• Taking On The World: Harmonization Is Not Always Simplification

Contract Sourcing

• RFP Reform: The Problem With Getting What You Ask For

Industry Leader

• Using Translational Pharmaceutics To Enhance Drug Development
• Smoothing The Road To An NDA
• The 21st Century Model Of Drug Discovery